The New Penal Code brings about significant changes to various aspects of the Current Penal Code, in particular regarding corporate liability and private corruption.
When senior government prosecutors discuss their white collar enforcement priorities, the prosecution of individuals frequently tops their list. However, holding company employees criminally responsible for corporate misconduct is easier said than done.
The PRC State Council released for public consultation draft amendments (“Draft Amendments”) to the PRC Anti-Unfair Competition Law (“AUCL”), the first time after more than 20 years since the AUCL’s enactment.
At the annual “SEC Speaks” conference on February 19, 2016 in Washington, DC, the head of the SEC’s FCPA Unit, Kara Brockmeyer, warned pharmaceutical companies that their industry will be under renewed scrutiny in 2016.
The Spanish Supreme Court ruled, for the first time, that companies can incur criminal liability.
The Crimes Legislation Amendment (Proceeds of Crime and Other Measures) Bill 2016 received Royal Assent, with significant implications for Australian companies and their foreign subsidiaries’ anti-bribery compliance programs.
Corporate compliance officers are used to facing pressure from within their companies to protect them from legal exposure, but increasingly, external pressure from regulators means that compliance officers themselves may face liability if something goes wrong.
Conspiracy charges continue to assist the government in overcoming the myriad legal obstacles to establishing a substantive FCPA violation.
The last four years have been a time of dramatic change for many companies in the U.S. aerospace and defense industry. At the same time, the FCPA risks increased.
Various Indonesian authorities, healthcare organizations and associations and representatives of national and international pharmaceutical companies agreed to an 8 point agreement on gratification in the healthcare sector.